In that trial, 4,286 (24.3%) of patients had heart failure with 1,347 of those patients having heart failure with reduced ejection fraction dwarfing the small numbers studied in the initial trials mentioned previously
By pairing GLP-1s with hormone optimization, youre addressing both the metabolic and endocrine causes of weight gain, helping prevent the rebound effect that can occur when one system is treated in isolation
Biernat W, Kordek R, Arkuszewska C, et al
Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility
Adverse events A total of 50 adverse events (AEs) were reported during this trial
Let our expert team help you discover the benefits of NAD and B12 injectables and set you on the path to a vibrant, energized spring.